Literature DB >> 8229380

Healing complications after internal fixation of trochanteric hip fractures: the prognostic value of osteoporosis.

C Barrios1, L A Broström, A Stark, G Walheim.   

Abstract

In a 3-year prospective randomized trial, the prognostic value of osteoporosis in terms of predicting healing complications due to implant failures or loss of fracture reduction has been studied in 113 patients with inter-trochanteric hip fractures treated with either a sliding screwplate or Ender nailing. According to the Barnet and Nordin's osteoporosis index, 66 patients were considered to have moderate or severe osteoporosis. There were no differences between patients with or without osteoporosis as regards the number of fractures with collapse in varus > 10 degrees, redislocation > 10 mm, or compression exceeding 10 mm. Six months after surgery, 48 patients failed in healing or healed with complications. These cases disclosed increased osteoporosis in comparison with those showing noncomplicated healing. Patients with osteoporosis who had unstable fractures treated by Ender nailing were found to have the worst prognosis for healing complications (p = 0.006). Of the 33 fractures with implant failures, 25 (76%) occurred in patients with osteoporosis (p = 0.04). In patients with osteoporosis, the frequency of mechanical failures was significantly higher in fractures with the device positioned incorrectly. Independently of the device used, patients with unstable trochanteric hip fractures and osteoporotic bone were the group with the highest risk for failures of the implant.

Entities:  

Mesh:

Year:  1993        PMID: 8229380     DOI: 10.1097/00005131-199310000-00006

Source DB:  PubMed          Journal:  J Orthop Trauma        ISSN: 0890-5339            Impact factor:   2.512


  35 in total

1.  The challenge: fracture treatment in osteoporotic bone.

Authors:  Erich Schneider; Joerg Goldhahn; Peter Burckhardt
Journal:  Osteoporos Int       Date:  2004-11-09       Impact factor: 4.507

Review 2.  Fixation principles in metaphyseal bone--a patent based review.

Authors:  R Curtis; J Goldhahn; R Schwyn; P Regazzoni; N Suhm
Journal:  Osteoporos Int       Date:  2004-11-03       Impact factor: 4.507

3.  Correlation between femoral offset loss and dynamic hip screw cut-out complications after pertrochanteric fractures: a case-control study.

Authors:  Baptiste Boukebous; Pascal Guillon; Eric Vandenbussche; Marc Antoine Rousseau
Journal:  Eur J Orthop Surg Traumatol       Date:  2018-04-27

Review 4.  Biomaterial scaffolds for treating osteoporotic bone.

Authors:  Julie A Sterling; Scott A Guelcher
Journal:  Curr Osteoporos Rep       Date:  2014-03       Impact factor: 5.096

Review 5.  The potential of gene therapy for fracture healing in osteoporosis.

Authors:  M Egermann; E Schneider; C H Evans; A W Baltzer
Journal:  Osteoporos Int       Date:  2005-01-15       Impact factor: 4.507

Review 6.  Animal models for fracture treatment in osteoporosis.

Authors:  Marcus Egermann; J Goldhahn; E Schneider
Journal:  Osteoporos Int       Date:  2005-03-05       Impact factor: 4.507

Review 7.  Conversion Total Hip Arthroplasty After Failed Basicervical Hip Fracture Fixation: A Case Report and Review of Literature.

Authors:  Vineet Tyagi; Oluwaseun Akinbo
Journal:  Iowa Orthop J       Date:  2017

8.  Outcome Analysis of Locking Plate Fixation in Proximal Humerus Fracture.

Authors:  Mayank Vijayvargiya; Abhishek Pathak; Sanjiv Gaur
Journal:  J Clin Diagn Res       Date:  2016-08-01

Review 9.  Mechanics and mechano-biology of fracture healing in normal and osteoporotic bone.

Authors:  Peter Augat; Ulrich Simon; Astrid Liedert; Lutz Claes
Journal:  Osteoporos Int       Date:  2004-09-15       Impact factor: 4.507

10.  Do estrogen and alendronate improve metaphyseal fracture healing when applied as osteoporosis prophylaxis?

Authors:  Leila Kolios; Ann Kristin Hoerster; Stephan Sehmisch; Marie Christin Malcherek; Thomas Rack; Mohammed Tezval; Dana Seidlova-Wuttke; Wolfgang Wuttke; Klaus Michael Stuermer; Ewa Klara Stuermer
Journal:  Calcif Tissue Int       Date:  2009-12-01       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.